1. Executive Summary
1.1. Global Cell Isolation Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Cell Isolation Market Outlook, 2018 - 2030
3.1. Global Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Reagent
3.1.1.2. Instrument
3.1.1.3. Other
3.2. Global Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Bio-Research Center
3.2.1.2. Hospital
3.2.1.3. Others
3.3. Global Cell Isolation Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Cell Isolation Market Outlook, 2018 - 2030
4.1. North America Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Reagent
4.1.1.2. Instrument
4.1.1.3. Other
4.2. North America Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Bio-Research Center
4.2.1.2. Hospital
4.2.1.3. Others
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Cell Isolation Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. U.S. Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
4.3.1.2. U.S. Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
4.3.1.3. Canada Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
4.3.1.4. Canada Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Cell Isolation Market Outlook, 2018 - 2030
5.1. Europe Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Reagent
5.1.1.2. Instrument
5.1.1.3. Other
5.2. Europe Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Bio-Research Center
5.2.1.2. Hospital
5.2.1.3. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Cell Isolation Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Germany Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.2. Germany Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.3. U.K. Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.4. U.K. Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.5. France Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.6. France Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.7. Italy Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.8. Italy Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.9. Turkey Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.10. Turkey Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.11. Russia Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.12. Russia Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.13. Rest of Europe Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
5.3.1.14. Rest of Europe Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cell Isolation Market Outlook, 2018 - 2030
6.1. Asia Pacific Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Reagent
6.1.1.2. Instrument
6.1.1.3. Other
6.2. Asia Pacific Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Bio-Research Center
6.2.1.2. Hospital
6.2.1.3. Others
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Cell Isolation Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. China Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.2. China Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.3. Japan Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.4. Japan Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.5. South Korea Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.6. South Korea Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.7. India Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.8. India Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.9. Southeast Asia Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.10. Southeast Asia Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.11. Rest of Asia Pacific Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
6.3.1.12. Rest of Asia Pacific Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Cell Isolation Market Outlook, 2018 - 2030
7.1. Latin America Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Reagent
7.1.1.2. Instrument
7.1.1.3. Other
7.2. Latin America Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Bio-Research Center
7.2.1.2. Hospital
7.2.1.3. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Cell Isolation Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Brazil Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
7.3.1.2. Brazil Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.3. Mexico Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
7.3.1.4. Mexico Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.5. Argentina Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
7.3.1.6. Argentina Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.7. Rest of Latin America Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
7.3.1.8. Rest of Latin America Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Cell Isolation Market Outlook, 2018 - 2030
8.1. Middle East & Africa Cell Isolation Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Reagent
8.1.1.2. Instrument
8.1.1.3. Other
8.2. Middle East & Africa Cell Isolation Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Bio-Research Center
8.2.1.2. Hospital
8.2.1.3. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Cell Isolation Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. GCC Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
8.3.1.2. GCC Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.3. South Africa Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
8.3.1.4. South Africa Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.5. Egypt Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
8.3.1.6. Egypt Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.7. Nigeria Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
8.3.1.8. Nigeria Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.9. Rest of Middle East & Africa Cell Isolation Market by Type, Value (US$ Bn), 2018 - 2030
8.3.1.10. Rest of Middle East & Africa Cell Isolation Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs ApplicationHeatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Beckman Coulter (U.S.)
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Becton
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Dickinson, and Company (U.S.)
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. GE Healthcare (U.K.)
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Merck KGaA (U.S.)
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Miltenyi Biotec (Germany)
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. PluriSelect (Germany)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. STEMCELL Technologies Inc. (Canada)
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Business Strategies and Development
9.4.9. Thermo Fisher Scientific
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Terumo BCT (U.S.)
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. PluriSelect Life Science UG & Co. KG
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Danaher
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Corning Inc.
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. GenScript
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. BD Bioscience
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations